ADMA Biologics' Reverse Merger Round

ADMA Biologics raised a round of funding on February 14, 2012. Investors include R&R Acquisition VI.

ADMA is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. ADMA…

Articles about ADMA Biologics' Reverse Merger Round: